AXP
71
2
MAS
58
2
DE
63
3
NVDA
56
-4
WBA
48
4
MA
64
7
CRM
67
2
LNC
39
3
ADT
53
3
ILMN
42
5
NWL
53
3
INTC
33
-2
FTI
81
5
JPM
69
2
ORCL
65
-2
FITB
63
3
NOC
43
11
A
43
2
FDX
43
3
CAH
48
-5
AXP
71
2
MAS
58
2
DE
63
3
NVDA
56
-4
WBA
48
4
MA
64
7
CRM
67
2
LNC
39
3
ADT
53
3
ILMN
42
5
NWL
53
3
INTC
33
-2
FTI
81
5
JPM
69
2
ORCL
65
-2
FITB
63
3
NOC
43
11
A
43
2
FDX
43
3
CAH
48
-5
Financhill
Back

NLS Pharmaceutics Quote, Financials, Valuation and Earnings

Invest. Do Good. Get Rewarded. Just $0.26/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
27

NLSP
NLS Pharmaceutics

Last Price:
3.48
Seasonality Move:
43.45%

7 Day Trial

ALL ACCESS PASS

$ 7

Trade on Tuesday. Profit on Friday. Rinse & Repeat

Get the full details now.

NLS Pharmaceutics Price Quote

$3.48
+0.05 (+3.42%)
(Updated: November 23, 2024 at 5:46 AM ET)

NLS Pharmaceutics Key Stats

Sell
27
NLS Pharmaceutics (NLSP) is a Sell
Day range:
$3.33 - $3.65
52-week range:
$3.00 - $29.08
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
0%
Volume:
64.4K
Avg. volume:
427.7K
1-year change:
-79.09%
Market cap:
$13.1M
Revenue:
$0
EPS:
$-6.74

How Much Does NLS Pharmaceutics Make?

Data Unavailable

Is NLS Pharmaceutics Growing As A Company?

Data Unavailable

NLS Pharmaceutics Stock Price Performance

  • Did NLS Pharmaceutics Stock Go Up Last Month?
    NLS Pharmaceutics share price went down by -29.13% last month
  • Did NLSP's Share Price Rise Over The Last Year?
    NLSP share price fell by -79.09% over the past 1 year

What Is NLS Pharmaceutics 52-Week High & Low?

NLS Pharmaceutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy NLS Pharmaceutics?

  • How Much Debt Does NLS Pharmaceutics Have?
    Total long term debt quarterly is $0
  • How Much Cash Does NLS Pharmaceutics Have?
    Cash and short term investments quarterly total is $552.8K
  • What Is NLS Pharmaceutics’s Book Value Per Share?
    Book value per share is -9.40

Is NLS Pharmaceutics Cash Flow Positive?

  • What Is NLSP Cash Flow From Operations?
    Cash flow from operations (TTM) is -$3.9M
  • What Is NLS Pharmaceutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $2.8M
  • What Is NLS Pharmaceutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $0

NLS Pharmaceutics Return On Invested Capital

Data Unavailable

NLS Pharmaceutics Earnings Date & Stock Price

NLS Pharmaceutics Competitors

  • Who Are NLS Pharmaceutics's Competitors?
    Below is a list of companies who compete with NLS Pharmaceutics or are related in some way:
    • AC Immune SA (ACIU)
    • Addex Therapeutics Ltd (ADXN)
    • CRISPR Therapeutics AG (CRSP)
    • MoonLake Immunotherapeutics (MLTX)
    • Molecular Partners AG (MOLN)

NLS Pharmaceutics Dividend Yield

NLS Pharmaceutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 240.00
Upside from Last Price: 6897.08%

Major Shareholders

  • How many NLSP shares are owned by institutional investors?
    261K NLSP shares are owned by institutional investors
  • How many NLSP shares are owned by insiders?
    0 NLSP shares are owned by insiders